Alkermes ALKS
NASDAQ ALKS
$45.31 -0.18 (-0.40%)
As of: Sep 9, 2026 · 2:06 PM EDT

Alkermes (ALKS) Receivables (2011 - 2026)

Alkermes' (ALKS) quarterly Receivables came in at $456.5 million in Q2 2026, up 28.11% year-over-year from $356.3 million in Q2 2025, and up 11.98% quarter-over-quarter from $407.6 million in Q1 2026.

Analysis

Alkermes (ALKS) Receivables (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Receivables for 16 consecutive years, with $456.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Receivables rose 28.11% year-over-year to $456.5 million in Q2 2026; TTM through Jun 2026 was $456.5 million, a 28.11% increase from a year earlier, with the FY2025 full-year figure at $399.8 million, down 11.94% from the prior year.
  • Receivables was $456.5 million for Q2 2026 at Alkermes, up from $407.6 million in the prior quarter.
  • Over five years, Receivables peaked at $456.5 million in Q2 2026 and troughed at $1.4 million in Q4 2023.
  • A 5-year average of $302.8 million and a median of $334.3 million in 2023 frame the typical range for Receivables.
  • Across the five-year window, Receivables slumped 92.09% in 2023 and jumped 27486.26% in 2024, its largest moves.
  • Over 5 years, Receivables stood at $17.9 million in 2022, then tumbled by 92.09% to $1.4 million in 2023, then jumped by 27486.26% to $389.5 million in 2024, then fell by 14.25% to $334.0 million in 2025, then jumped by 36.66% to $456.5 million in 2026.
  • The last three Receivables figures came in at $456.5 million (Q2 2026), $407.6 million (Q1 2026), and $334.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 646.24 Bn 625.48 Bn 17.26 Bn 19.05 Bn
2 AbbVie 441.52 Bn 434.96 Bn 12.70 Bn 13.82 Bn
3 Merck 365.75 Bn 358.60 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 266.61 Bn 258.92 Bn 11.24 Bn 9.64 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn 12.49 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 10.13 Bn
7 Revolution Medicines 44.04 Bn 44.04 Bn - -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 1.13 Bn
9 United Therapeutics 21.43 Bn 18.77 Bn 683.80 Mn 310.30 Mn
10 Alkermes 7.56 Bn 6.90 Bn 397.90 Mn 456.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 456.48 Mn
Mar 31, 2026 407.63 Mn
Dec 31, 2025 334.03 Mn
Sep 30, 2025 355.11 Mn
Jun 30, 2025 356.33 Mn
Mar 31, 2025 321.75 Mn
Dec 31, 2024 389.52 Mn
Sep 30, 2024 370.18 Mn
Jun 30, 2024 369.91 Mn
Mar 31, 2024 317.08 Mn
Dec 31, 2023 1.41 Mn
Sep 30, 2023 340.46 Mn
Jun 30, 2023 334.48 Mn
Mar 31, 2023 277.61 Mn
Dec 31, 2022 17.86 Mn
Sep 30, 2022 267.28 Mn
Jun 30, 2022 262.33 Mn
Mar 31, 2022 270.15 Mn
Dec 31, 2021 26.73 Mn
Sep 30, 2021 292.67 Mn